Small molecule bioanalysis by LC-MS/MS
Industry leading small molecule bioanalysis
With a focused strategic science team and one of the largest purpose-built bioanalytical facilities in Europe, we continue to pioneer development of sensitive and reliable small molecule methods on our state-of-the-art LC-MS/MS platforms. We have an industry leading 50+ years’ experience of providing bioanalytical services and 20+ years working to GLP and GCP applying novel technologies to help answer your analytical challenges.
Integrated support from early discovery to late phase clinical trials
Recognised for our leadership in science and technology, our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies. The LGC approach provides an integrated solution of experts throughout the drug development pipeline. We provide you with a single point of contact facilitating superior levels of accountability, efficiency and clarity of communication.
Our integrated services include:
- Fast method development / analysis for discovery compounds
- Method development and validation for GLP TK studies and GCP clinical trials
- Fast turnaround for Phase I Clinical Studies
- Biomarkers by LC-MS/MS
- Pharmacokinetic data analysis using validated software systems (e.g. WinNonlin,)
- Logistical support for clinical sample management including sample collection kit production production and supply of sampling kits, labels, investigator manual and shipping
- Data management using LIMS or specialist software
Working with you to meet the shortest possible sample analysis timelines, we are committed to providing data of the highest quality, using robust bioanalytical methods. We strive to ensure that our labs are an extension of your company and project team to deliver seamless support of your drug development programme.